Which has stronger earnings & valuation, ITGR or STAA?

Integer has higher revenue and earnings than STAAR Surgical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.85B 2.32 $102.81M $2.98 42.50 STAAR Surgical $239.44M 5.53 -$80.45M N/A N/A

Does the media prefer ITGR or STAA?

In the previous week, STAAR Surgical had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for STAAR Surgical and 1 mentions for Integer. STAAR Surgical's average media sentiment score of 0.64 beat Integer's score of 0.00 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral STAAR Surgical 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, STAA or PLSE?

Pulse Biosciences has lower revenue, but higher earnings than STAAR Surgical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STAAR Surgical $239.44M 5.53 -$80.45M N/A N/A Pulse Biosciences $1.49M 2,483.14 -$72.78M -$1.21 N/A

Does the media refer more to STAA or PLSE?

In the previous week, STAAR Surgical and STAAR Surgical both had 7 articles in the media. STAAR Surgical's average media sentiment score of 0.64 beat Pulse Biosciences' score of 0.20 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulse Biosciences 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher valuation & earnings, TMDX or STAA?

TransMedics Group has higher revenue and earnings than STAAR Surgical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio TransMedics Group $605.49M 5.24 $190.29M $3.69 24.76 STAAR Surgical $239.44M 5.53 -$80.45M N/A N/A

Does the media favor TMDX or STAA?

In the previous week, TransMedics Group had 13 more articles in the media than STAAR Surgical. MarketBeat recorded 18 mentions for TransMedics Group and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.64 beat TransMedics Group's score of 0.49 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 4 Very Positive mention(s) 0 Positive mention(s) 10 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral STAAR Surgical 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, STAA or AXGN?

AxoGen has higher revenue and earnings than STAAR Surgical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STAAR Surgical $239.44M 5.53 -$80.45M N/A N/A AxoGen $266.93M 12.52 -$15.70M -$0.65 N/A

Is STAA or AXGN more profitable?

STAAR Surgical has a net margin of 0.16% compared to AxoGen's net margin of -11.96%. STAAR Surgical's return on equity of 8.43% beat AxoGen's return on equity. Company Net Margins Return on Equity Return on Assets STAAR Surgical 0.16% 8.43% 6.50% AxoGen -11.96% -5.35% -4.41%

Does the media prefer STAA or AXGN?

In the previous week, AxoGen had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 7 mentions for AxoGen and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.64 beat AxoGen's score of 0.38 indicating that STAAR Surgical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AxoGen 0 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, STAA or ATRC?

AtriCure has higher revenue and earnings than STAAR Surgical. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STAAR Surgical $239.44M 5.53 -$80.45M N/A N/A AtriCure $534.53M 5.41 -$11.45M $0.30 189.47

Does the media refer more to STAA or ATRC?

In the previous week, AtriCure had 1 more articles in the media than STAAR Surgical. MarketBeat recorded 8 mentions for AtriCure and 7 mentions for STAAR Surgical. AtriCure's average media sentiment score of 0.88 beat STAAR Surgical's score of 0.64 indicating that AtriCure is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 1 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

STAAR Surgical (STAA) Competitors

$26.39 -0.39 (-1.46%)

Closing price 11/13/2026 04:00 PM Eastern

Extended Trading

$25.73 -0.66 (-2.50%)

As of 11/13/2026 07:30 PM Eastern

Compare

STAA vs. ITGR, PLSE, TMDX, AXGN, and ATRC

Should you buy STAAR Surgical stock or one of its competitors? STAAR Surgical's main competitors and comparable companies include Integer (ITGR), Pulse Biosciences (PLSE), TransMedics Group (TMDX), AxoGen (AXGN), and AtriCure (ATRC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does STAAR Surgical compare to Integer?

Integer (NYSE:ITGR) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, valuation, risk, institutional ownership, analyst recommendations and earnings.

Integer has a net margin of 5.68% compared to STAAR Surgical's net margin of 0.16%. Integer's return on equity of 11.84% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	5.68%	11.84%	5.98%
STAAR Surgical	0.16%	8.43%	6.50%

Integer has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market.

Integer currently has a consensus target price of $113.67, suggesting a potential downside of 10.25%. STAAR Surgical has a consensus target price of $29.00, suggesting a potential upside of 9.89%. Given STAAR Surgical's stronger consensus rating and higher probable upside, analysts plainly believe STAAR Surgical is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	11 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.08
STAAR Surgical	3 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.23

99.3% of Integer shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 1.1% of Integer shares are held by company insiders. Comparatively, 39.9% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Integer has higher revenue and earnings than STAAR Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.85B	2.32	$102.81M	$2.98	42.50
STAAR Surgical	$239.44M	5.53	-$80.45M	N/A	N/A

In the previous week, STAAR Surgical had 6 more articles in the media than Integer. MarketBeat recorded 7 mentions for STAAR Surgical and 1 mentions for Integer. STAAR Surgical's average media sentiment score of 0.64 beat Integer's score of 0.00 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
STAAR Surgical	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

STAAR Surgical beats Integer on 10 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to Pulse Biosciences?

STAAR Surgical (NASDAQ:STAA) and Pulse Biosciences (NASDAQ:PLSE) are both healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations and risk.

STAAR Surgical has a beta of 1.22, meaning that its share price is 22% more volatile than the broader market. Comparatively, Pulse Biosciences has a beta of 1.65, meaning that its share price is 65% more volatile than the broader market.

Pulse Biosciences has lower revenue, but higher earnings than STAAR Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.53	-$80.45M	N/A	N/A
Pulse Biosciences	$1.49M	2,483.14	-$72.78M	-$1.21	N/A

STAAR Surgical has a net margin of 0.16% compared to Pulse Biosciences' net margin of -5,603.88%. STAAR Surgical's return on equity of 8.43% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	0.16%	8.43%	6.50%
Pulse Biosciences	-5,603.88%	-77.88%	-67.89%

96.7% of STAAR Surgical shares are held by institutional investors. Comparatively, 76.9% of Pulse Biosciences shares are held by institutional investors. 39.9% of STAAR Surgical shares are held by company insiders. Comparatively, 74.0% of Pulse Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

STAAR Surgical presently has a consensus price target of $29.00, indicating a potential upside of 9.89%. Pulse Biosciences has a consensus price target of $66.60, indicating a potential upside of 32.04%. Given Pulse Biosciences' stronger consensus rating and higher possible upside, analysts plainly believe Pulse Biosciences is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.23
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	2.86

In the previous week, STAAR Surgical and STAAR Surgical both had 7 articles in the media. STAAR Surgical's average media sentiment score of 0.64 beat Pulse Biosciences' score of 0.20 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pulse Biosciences	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Pulse Biosciences beats STAAR Surgical on 8 of the 14 factors compared between the two stocks.

How does STAAR Surgical compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 6.9% of TransMedics Group shares are owned by company insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

TransMedics Group has a net margin of 19.85% compared to STAAR Surgical's net margin of 0.16%. TransMedics Group's return on equity of 13.30% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	19.85%	13.30%	4.93%
STAAR Surgical	0.16%	8.43%	6.50%

TransMedics Group has a beta of 2.14, meaning that its stock price is 114% more volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market.

TransMedics Group currently has a consensus price target of $113.30, suggesting a potential upside of 23.99%. STAAR Surgical has a consensus price target of $29.00, suggesting a potential upside of 9.89%. Given TransMedics Group's stronger consensus rating and higher probable upside, equities analysts clearly believe TransMedics Group is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	0 Sell rating(s)	7 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.42
STAAR Surgical	3 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.23

TransMedics Group has higher revenue and earnings than STAAR Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	5.24	$190.29M	$3.69	24.76
STAAR Surgical	$239.44M	5.53	-$80.45M	N/A	N/A

In the previous week, TransMedics Group had 13 more articles in the media than STAAR Surgical. MarketBeat recorded 18 mentions for TransMedics Group and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.64 beat TransMedics Group's score of 0.49 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	4 Very Positive mention(s)	0 Positive mention(s)	10 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
STAAR Surgical	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

TransMedics Group beats STAAR Surgical on 11 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to AxoGen?

STAAR Surgical (NASDAQ:STAA) and AxoGen (NASDAQ:AXGN) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, profitability, earnings, institutional ownership and dividends.

AxoGen has higher revenue and earnings than STAAR Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.53	-$80.45M	N/A	N/A
AxoGen	$266.93M	12.52	-$15.70M	-$0.65	N/A

STAAR Surgical has a net margin of 0.16% compared to AxoGen's net margin of -11.96%. STAAR Surgical's return on equity of 8.43% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	0.16%	8.43%	6.50%
AxoGen	-11.96%	-5.35%	-4.41%

In the previous week, AxoGen had 2 more articles in the media than STAAR Surgical. MarketBeat recorded 7 mentions for AxoGen and 5 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.64 beat AxoGen's score of 0.38 indicating that STAAR Surgical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AxoGen	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 2.4% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

STAAR Surgical has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, AxoGen has a beta of 1.21, suggesting that its share price is 21% more volatile than the broader market.

STAAR Surgical presently has a consensus target price of $29.00, indicating a potential upside of 9.89%. AxoGen has a consensus target price of $57.92, indicating a potential upside of 3.55%. Given STAAR Surgical's higher possible upside, research analysts clearly believe STAAR Surgical is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.23
AxoGen	1 Sell rating(s)	2 Hold rating(s)	13 Buy rating(s)	0 Strong Buy rating(s)	2.75

Summary

STAAR Surgical beats AxoGen on 9 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to AtriCure?

STAAR Surgical (NASDAQ:STAA) and AtriCure (NASDAQ:ATRC) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings and media sentiment.

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 4.0% of AtriCure shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

AtriCure has a net margin of 2.52% compared to STAAR Surgical's net margin of 0.16%. STAAR Surgical's return on equity of 8.43% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	0.16%	8.43%	6.50%
AtriCure	2.52%	4.01%	3.03%

STAAR Surgical currently has a consensus price target of $29.00, indicating a potential upside of 9.89%. AtriCure has a consensus price target of $62.30, indicating a potential upside of 9.61%. Given STAAR Surgical's higher possible upside, analysts clearly believe STAAR Surgical is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.23
AtriCure	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.58

STAAR Surgical has a beta of 1.22, suggesting that its share price is 22% more volatile than the broader market. Comparatively, AtriCure has a beta of 1.23, suggesting that its share price is 23% more volatile than the broader market.

In the previous week, AtriCure had 1 more articles in the media than STAAR Surgical. MarketBeat recorded 8 mentions for AtriCure and 7 mentions for STAAR Surgical. AtriCure's average media sentiment score of 0.88 beat STAAR Surgical's score of 0.64 indicating that AtriCure is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	1 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure has higher revenue and earnings than STAAR Surgical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.53	-$80.45M	N/A	N/A
AtriCure	$534.53M	5.41	-$11.45M	$0.30	189.47

Summary

AtriCure beats STAAR Surgical on 10 of the 15 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STAA vs. The Competition

Export

Metric	STAAR Surgical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.34B	$5.96B	$7.84B	$12.19B
Dividend Yield	N/A	1.68%	2.46%	4.53%
P/E Ratio	-2,639,000.00	38.39	34.71	28.44
Price / Sales	5.53	5.57	8.66	5.84
Price / Cash	N/A	23.95	21.93	22.49
Price / Book	3.52	4.45	4.35	3.76
Net Income	-$80.45M	$143.14M	$3.51B	$390.55M
7 Day Performance	4.68%	-1.25%	-1.49%	-0.33%
1 Month Performance	20.83%	-1.30%	-2.55%	-4.82%
1 Year Performance	0.27%	1.73%	0.92%	-5.83%

STAAR Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAA STAAR Surgical	2.2511 of 5 stars	$26.39 -1.5%	$29.00 +9.9%	+1.4%	$1.34B	$239.44M	N/A	957	Analyst Forecast
ITGR Integer	1.0566 of 5 stars	$126.66 +0.1%	$113.67 -10.3%	+86.4%	$4.31B	$1.85B	42.50	11,000
PLSE Pulse Biosciences	3.42 of 5 stars	$53.91 -7.3%	$66.60 +23.5%	+256.7%	$3.82B	$350K	N/A	116
TMDX TransMedics Group	4.3252 of 5 stars	$90.66 -3.3%	$113.30 +25.0%	-20.9%	$3.14B	$605.49M	24.61	898
AXGN AxoGen	1.8613 of 5 stars	$50.50 -0.3%	$57.92 +14.7%	+132.7%	$3.01B	$225.21M	N/A	622

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STAA) was last updated on 11/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAAR Surgical (STAA) Competitors

STAA vs. ITGR, PLSE, TMDX, AXGN, and ATRC

How does STAAR Surgical compare to Integer?

Summary

How does STAAR Surgical compare to Pulse Biosciences?

Summary

How does STAAR Surgical compare to TransMedics Group?

Summary

How does STAAR Surgical compare to AxoGen?

Summary

How does STAAR Surgical compare to AtriCure?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STAAR Surgical (STAA) Competitors

STAA vs. ITGR, PLSE, TMDX, AXGN, and ATRC

How does STAAR Surgical compare to Integer?

Is ITGR or STAA more profitable?

Which has more risk & volatility, ITGR or STAA?

Do analysts rate ITGR or STAA?

Do institutionals and insiders have more ownership in ITGR or STAA?

Which has stronger earnings & valuation, ITGR or STAA?

Does the media prefer ITGR or STAA?

Summary

How does STAAR Surgical compare to Pulse Biosciences?

Which has more volatility & risk, STAA or PLSE?

Which has preferable valuation and earnings, STAA or PLSE?

Is STAA or PLSE more profitable?

Do insiders & institutionals believe in STAA or PLSE?

Do analysts prefer STAA or PLSE?

Does the media refer more to STAA or PLSE?

Summary

How does STAAR Surgical compare to TransMedics Group?

Do insiders and institutionals hold more shares of TMDX or STAA?

Is TMDX or STAA more profitable?

Which has more volatility & risk, TMDX or STAA?

Do analysts prefer TMDX or STAA?

Which has higher valuation & earnings, TMDX or STAA?

Does the media favor TMDX or STAA?

Summary

How does STAAR Surgical compare to AxoGen?

Which has stronger valuation and earnings, STAA or AXGN?

Is STAA or AXGN more profitable?

Does the media prefer STAA or AXGN?

Do institutionals & insiders believe in STAA or AXGN?

Which has more risk and volatility, STAA or AXGN?

Do analysts prefer STAA or AXGN?

Summary

How does STAAR Surgical compare to AtriCure?

Do insiders and institutionals believe in STAA or ATRC?

Is STAA or ATRC more profitable?

Do analysts rate STAA or ATRC?

Which has more volatility & risk, STAA or ATRC?

Does the media refer more to STAA or ATRC?

Which has stronger valuation & earnings, STAA or ATRC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools